Showing results (671-680 of 1,074) with videos related to
Sort By:
Pageof 108
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 15, 2018
Current use of intracoronary imaging in interventional practice - Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice SurveyKonstantinos C Koskinas, Masato Nakamura, Lorenz Räber, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 28, 2020
Statistical methods for composite endpointsHironori Hara, David van Klaveren, Norihiro Kogame, et al.European Heart Journal|May 23, 2019
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding RiskPhilip Urban, Roxana Mehran, Roisin Colleran, et al.Circulation|May 23, 2019
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary InterventionPhilip Urban, Roxana Mehran, Roisin Colleran, et al.Nature Reviews. Cardiology|January 23, 2026
Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapiesMattia Galli, Antonio Abbate, Marc P Bonaca, et al.Journal of the American College of Cardiology|June 6, 2006
Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) TrialPilar Jiménez-Quevedo, Manel Sabaté, Dominick J Angiolillo, et al.Platelets|November 28, 2006
Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery diseaseEsther Bernardo, Dominick J Angiolillo, Celia Ramírez, et al.The American Journal of Cardiology|October 24, 2006
Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery diseaseEsther Bernardo, Dominick J Angiolillo, Celia Ramírez, et al.Thrombosis and Haemostasis|May 24, 2023
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) StudyLuis Ortega-Paz, Francesco Franchi, Fabiana Rollini, et al.Journal of the American College of Cardiology|October 16, 2007
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery diseaseDominick J Angiolillo, Esther Bernardo, Manel Sabaté, et al.Pageof 108